Big Pharma set for more Senate scrutiny as Democrats eye pricing, tax probes: report fkansteiner Mon, 01/23/2023 – 14:30 More: Big Pharma set for more Senate scrutiny as Democrats eye pricing, tax probes: report Source: fierce
read moreAs antibiotics run scarce, Europe outlines drug shortage countermeasures fkansteiner Mon, 01/23/2023 – 10:49 More: As antibiotics run scarce, Europe outlines drug shortage countermeasures Source: fierce
read moreTakeda pledges up to $1.13B for rights to Hutchmed’s cancer drug fruquintinib outside of China kdunleavy Mon, 01/23/2023 – 09:49 More: Takeda pledges up to .13B for rights to Hutchmed's cancer drug fruquintinib outside of China Source: fierce
read moreBayer chairman under fire for lack of spinoff activity amid renewed investor activism aliu Mon, 01/23/2023 – 09:46 More: Bayer chairman under fire for lack of spinoff activity amid renewed investor activism Source: fierce
read moreWith TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena fkansteiner Mon, 01/23/2023 – 09:16 More: With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena Source: fierce
read moreTreatment is a maintenance therapy for certain patients with acute myeloid leukaemia More: First patients enrolled for Priothera’s mocravimod trial Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals